| CARSON CITY, Nev., Feb. 6, 2012 /PRNewswire/ -- OphthaliX Inc. (OTCBB: OPLI) is pleased to announce the appointment of Professor Roger D. Kornberg to the Company's Board of Directors. Roger Kornberg is Winzer Professor in Medicine in the Department of Structural Biology at Stanford University. He moved to his present position in 1978, where his research has focused on the mechanism and regulation of eukaryotic gene transcription. In 2006, Professor Kornberg was awarded the Nobel Prize in Chemi...continued OPLI |
SmallCapUpdates provides the latest news and alerts on stocks for you. If you are looking for the latest on stocks in clean energy, medical innovation, mining, biotech, nanotech, renewable energy, internet technology or in emerging markets.
Monday, February 6, 2012
OphthaliX Announces the Appointment of Prof. Roger Kornberg as a Director
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment